tbuckley/cabot-search huggingface dataset:
A Bioinformatics Approach to Establishing Novel Transforming Growth Factor-Beta Target Genes in Glioblastoma.
Authors: Alice Willison, Richard Taylor, Kismet Hossain-Ibrahim, Gareth Inman
Journal: Neuro-Oncology (2019)

Abstract Introduction TGFβ inhibition is becoming an increasingly exciting prospect for the treatment of glioblastoma (GBM) as more about its efficacy is understood. However, there is little demonstrated improvement in patient outcomes from clinical trials using small molecule inhibitors of the TGFβ receptors. Clearly, the potential of TGFβ therapy has not yet been realised. We scrutinised the TGFβ canonical genes at a cytogenetic, genetic and gene expression level for novel therapeutic targets. Materials and Methods 10 canonical TGFβ genes were analysed. Karyotypes were interpreted using the International System for Human Cytogenetic Nomenclature and graphics generated using the Cytogenetic Data Analysis System. Analysis and generation of graphics were carried out using The Cancer Genome Atlas (TCGA) Provisional Glioblastoma set of 290 whole-exome-sequenced tumours via cBioPortal. mRNA expression data were extracted from The Cancer Genome Atlas (TCGA) via cBioPortal. Kaplan-Meier graphs were generated using GraphPad Prism®, for which pairwise log rank comparisons were conducted to determine a difference in both overall survival (OS) and disease-free, progression-free (DFPF) survival. Results At cytogenetic and genetic levels, TGFβ genes are not markedly altered in GBM. However, mRNA expression of TGFβ2 is enhanced in GBM compared to other cancers. In addition, we correlated upregulation of both SMAD7 and SARA with improved OS and upregulation of SARA with improved DFPF survival. Conclusions TGFβ2 upregulation may be associated with GBM tumourigenesis and SMAD7 and SARA upregulation may be associated with improved survival. We demonstrate that three canonical genes have therapeutic potential, but their conflicting roles must be further understood before TGFβ-modulating therapies are successful.
Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis
Authors: Derek To, Dawn Warkentin, Raewyn Broady, Kevin Song, Michael J. Barnett, Donna L. Forrest, Thomas J. Nevill, Stephen H. Nantel, John D. Shepherd, Donna E. Hogge, Cynthia L. Toze, Sujaatha Narayanan, Yasser Abou Mourad, Heather J. Sutherland, Maryse M. Power
Journal: Blood (2011)
CD200 and PD1-L1 in AML Are Associated with Expanded PD-1+ Late Differentiated CD8+ T Cells and a Decreased CD4:CD8 Ratio: a New Link Between Distinct Immunosuppressive Pathways
Authors: Steven Coles, Marie N Gilmore, Reiss Reid, Steven Knapper, Alan K. Burnett, Steven Man, Alex Tonks, Richard L Darley
Journal: Blood (2014)
Combined Inhibition of JAK2 and mTOR Signaling Results in Enhanced Efficacy in in-Vitro and Preclinical Mouse Models of JAK2V617F-Driven Myeloproliferative Disease
Authors: Alessandro M. Vannucchi, Niccolò Bartalucci, Costanza Bogani, Serena Martinelli, Lorenzo Tozzi, Alberto Bosi, Jean-Luc Villeval
Journal: Blood (2012)
Predicting meningioma recurrence using spectrochemical analysis of tissues and subsequent predictive computational algorithms
Authors: Taha Lilo, Camilo Morais, Kate Ashton, Ana Pardilho, Timothy Dawson, Nihal Gurusinghe, Charles Davis, Frank Martin
Journal: Neuro-Oncology (2019)

Abstract Introduction Meningioma recurrence remains a clinical dilemma. This has a significant clinical and huge financial implication. Hence, the search for predictors for meningioma recurrence has become an increasingly urgent research topic in recent years. Objective Using spectrochemical analytical methods such as attenuated total reflection Fourier-transform infrared (ATR-FTIR) and Raman spectroscopy, our primary objective is to compare the spectral fingerprint signature of WHO grade I meningioma vs. WHO grade I meningioma that recurred. Secondary objectives compare WHO grade I meningioma vs. WHO grade II meningioma and WHO grade II meningioma vs. WHO grade I meningioma recurrence. Materials and Methods Our selection criteria included convexity meningioma only restricted to Simpson grade I &amp; II only and WHO grade I &amp; grade II only with a minimum 5 years follow up. We obtained tissue from tumour blocks retrieved from the tissue bank. These were sectioned onto slides and de-waxed prior to ATR-FTIR or Raman spectrochemical analysis. Derived spectral datasets were then explored for discriminating features using computational algorithms in the IRootLab toolbox within MATLAB; this allowed for classification and feature extraction. Results After analysing the data using various classification algorithms with cross-validation to avoid over-fitting of the spectral data, we can readily and blindly segregate those meningioma samples that recurred from those that did not recur in the follow-up timeframe. The forward feature extraction classification algorithms generated results that exhibited excellent sensitivity and specificity, especially with spectra obtained following ATR-FTIR spectroscopy. Our secondary objectives remain to be fully developed.
Clinical and Prognostic Implications of Low or High Level of Von Willebrand Factor (VWF) In Waldenström Macroglobulinemia (WM) Patients (pts). A Clinicopathological Study on 72 Pts
Authors: Bénédicte Hivert, Claudine Caron, Stéphanie Petit, Cécile Charpy, Corinne Fankam-Siaka, Alain Duhamel, Olivier Tournilhac, Jenny Goudemand, Pierre Morel
Journal: Blood (2010)
The History of Orthopaedics: An Account of the Study and Practice of Orthopaedics from the Earliest Times to the Modern Era
Journal: Annals of Internal Medicine (1991)

Prehistory and ancient Egypt ancient India ancient China ancient Japan ancient Greece ancient Rome the Moslem Empire medieval times England - Germany - Austria - France - Italy - Switzerland - the Netherlands - Scandinavia - New Zealand - the United States - Latin America amputations and prostheses club foot congenital dislocation of the hip scoliosis bone grafting.
Elevated Serum Interleukin-7 Levels Precede the Development of Acute Graft-Versus-Host Disease.
Authors: Robert M. Dean, Terry Fry, Crystal Mackall, Seth M. Steinberg, Frances T. Hakim, Daniel H. Fowler, Jeanne Odom, Jason Foley, Ronald E. Gress, Michael R. Bishop
Journal: Blood (2007)
Lintuzumab and Low-Dose Cytarabine Compared to Placebo and Low-Dose Cytarabine in Patients with Untreated Acute Myeloid Leukemia (AML) 60 Years and Older: Results of a Randomized, Double-Blinded Phase 2b Study,
Authors: Jeffrey E. Lancet, Mikkael A. Sekeres, Brent L. Wood, Laurie E. Grove, Larissa Sandalic, Eric L. Sievers, Joseph G. Jurcic
Journal: Blood (2011)
Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial
Authors: Max S. Topp, Nicola Goekbuget, Gerhard Zugmaier, Andreas Viardot, Matthias Stelljes, Svenja Neumann, Heinz A. Horst, Albrecht Reichle, Reinhard E Marks, Monika Brueggemann, Matthias Ritgen, Petra Klappers, Noemi Mergen, Marie-Elisabeth Goebeler, Hermann Einsele, Dieter Hoelzer, Ralf Bargou
Journal: Blood (2011)
Updated Survival Analysis from the CLL11 Study: Obinutuzumab Versus Rituximab in Chemoimmunotherapy-Treated Patients with Chronic Lymphocytic Leukemia
Authors: Valentin Goede, Kirsten Fischer, Francesc Bosch, George Follows, Henrik Frederiksen, Antonio Cuneo, Heinz Ludwig, Noelle Crompton, Joerg Maurer, Marianne Uguen, Gunter Fingerle-Rowson, Michael Hallek
Journal: Blood (2015)
Clinical and Molecular Characterization of p53-Mutated Acute Myeloid Leukemia
Authors: Tapan Kadia, Jorge E. Cortes, Farhad Ravandi, Guillermo Garcia-Manero, Michael Andreeff, Koichi Takahashi, Gautam Borthakur, Elias J. Jabbour, Kapil N. Bhalla, Marina Konopleva, Naval Daver, Courtney DiNardo, Prithviraj Bose, Keyur P. Patel, Sherry Pierce, Hagop M. Kantarjian
Journal: Blood (2015)
High Incidence of TET2 Mutation in Chinese Patients with MDS and AML with Previous History of MDS
Authors: Lin Li, Zhu Xuejun, Jiang Pengjun, Zhang Wenxi, Yu Hui, Lin Lin, Chen Jianyi, Kong Xiangtu, Ni Haiwen, Wu Yu, Xu Zuqiong, Shen Qun, Ji Ou, Zhu Guangrong, Yang Yueyan, Li Jun, Ji Jianmin, Xuemei Sun
Journal: Blood (2012)
The adipose tissue that surrounds the prostate gland exhibits traits of hypoxic state that could contribute to its role in prostate cancer progression
Authors: M. Roumiguie, C. Manceau, D. Estève, C. Belles, J. Gilleron, A. Bouloumié, B. Malavaud, D. Milhas, C. Muller
Journal: European Urology (2021)
Maternal Embryonic Leucine Zipper Kinase (MELK): a Novel Marker of Poor Prognosis and Attractive Drug Target in High-Risk Patients with Multiple Myeloma
Authors: Arnold Bolomsky, Karin Schlangen, Artur Köhler, Goran Mitulovic, Wolfgang Schreiner, Niklas Zojer, Heinz Ludwig
Journal: Blood (2015)
Exploring the HLA-A Associations in EBV-Associated Classical Hodgkin Lymphoma : HLA-A Genotype Modifies the HLA-A*02:01 Restricted Cytotoxic T-Cell and Cytokine Response to EBV
Authors: Katrina Farrell, Karen A McAulay, Dorothy Montgomery, Annette Lake, Ann-Margaret Little, Ruth F Jarrett
Journal: Blood (2012)
Duvelisib (IPI-145), a Phosphoinositide-3-Kinase-δ,γ Inhibitor, Shows Activity in Patients with Relapsed/Refractory T-Cell Lymphoma
Authors: Steven M. Horwitz, Pierluigi Porcu, Ian Flinn, Brad S. Kahl, Jennifer Sweeney, Howard M. Stern, Mark Douglas, Kerstin Allen, Patrick Kelly, Francine M. Foss
Journal: Blood (2014)
FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?
Authors: Marine Boulesteix, Mohamed Touati, Julie Abraham, Sandrine Verbeke, Assmae El Badaoui, Marie Pierre Gourin, Agnes Olivrie, Manuela Delage Corre, Benoit Marin, Arnaud Jaccard, Dominique Bordessoule, Jacques Monteil
Journal: Blood (2012)
Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets
Authors: Ivan Dlouhy, Kennosuke Karube, Anna Enjuanes, David Martín-García, Ferran Nadeu, Gonzalo R Ordoñez, Jordina Rovira, Cristina Royo, Alba Navarro, Blanca Gonzalez, Giancarlo Castellano, Carlota Rubio-Perez, David Tamborero, Javier Briones, Antonio Salar, Juan-Manuel Sancho, Santiago Mercadal, Eva Gonzalez Barca, Lourdes Escoda, Miyoshi Hiroaki, Koichi Ohshima, Koji Kato, Koichi Akashi, Anna Mozos, Lluis Colomo, Miguel Alcoceba, Alexandra Valera, Anna Carrio, Nuria Lopez-Bigas, Roland Schmitz, Louis Staudt, Pedro Jares, Itziar Salaverria, Armando López-Guillermo, Elias Campo
Journal: Blood (2016)
Platelet Lymphocyte Ratio (PLR) Related with Clinicopathological Characteristics of Balinese Women Breast Cancer Patient
Authors: Sinta Wiranata, Putu Anda Tusta Adiputra, Anak Agung Wiradewi Lestari, I Putu Yuda Prabawa, I Gde Putu Supadmanaba
Journal: Annals of Oncology (2019)
Caspase-Activating Protein Nalp1 Is Directly Suppressed by Bcl-2 and Bcl-Xl.
Authors: Jean Marie Bruey, Nathalie Bruey-Sedano, Frederic Luciano, Dayong Zhai, Andrei Osterman, Shu-ichi Matsuzawa, Alexey Terskikh, Benjamin Faustin, John C. Reed
Journal: Blood (2006)
Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation
Authors: Adrian Britschgi, Hans-Uwe Simon, Andreas Tobler, Martin F. Fey, Mario P. Tschan
Journal: Blood (2008)
Post-Polycythemia and Post-Thrombocythemia Myelofibrosis Have Distinctive Clinical Phenotypes: An International Multicenter Study on 718 Patients
Authors: Domenica Caramazza, Margherita Maffioli, Mario Cazzola, Alessandro Maria Vannucchi, Alessandro Rambaldi, Enrica Morra, Jean-Jacques Kiladjian, Rami S Komrokji, Jason Gotilib, Francisco Cervantes, Paola Guglielmelli, Timothy Devos, Richard T. Silver, Nicola Vianelli, Valerio De Stefano, Marco Ruggeri, Alessandra Ricco, Giulia Benevolo, Barbara Mora, Tiziano Barbui, Lisa Pieri, Cristiana Pascutto, Elisa Rumi, Francesco Passamonti
Journal: Blood (2014)
Transfusion Dependency Is Associated With Inferior Survival Even In Very Low and Low Risk IPSS-R Patients
Authors: Devendra K. Hiwase, Monika M Kutyna, Rakchha Chhetri, Stuart Howell, Peter B Harrison, Shriram V Nath, Lakshmi S Nath, Nicholas Wickham, Ferenc Szabo, Chi-Hung Hui, David Ross, James Gray, Junia V Melo, Peter Bardy, L. Bik To
Journal: Blood (2013)
Announcing The Lancet Global Health Commission on Global Eye Health
Authors: Matthew J Burton, Hannah B Faal, Jacqueline Ramke, Thulasiraj Ravilla, Peter Holland, Ningli Wang, Sheila K West, Rupert R A Bourne, Nathan G Congdon, Allen Foster
Journal: The Lancet Global Health (2019)

Eye health has profound and widespread implications for many aspects of life, health, sustainable development, and the economy. Yet many populations do not have access to good-quality, affordable eye care.
Higher Doses of Transplanted T and B Cells Are Associated with Greater Incidence of Extensive Chronic GVHD after PBSC Transplantation from HLA-Identical Sibling Donors.
Authors: Frederic Baron, Brenda M. Sandmaier, Ted Gooley, Paul L. Martin, Mary E.D. Flowers, Michael L. Linenberger, Rainer F. Storb, Frederick R. Appelbaum, Shelly Heimfeld
Journal: Blood (2007)
The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis
Authors: Katharine He Xing, Joseph M. Connors, Mubarak Al-Mansour, Randy D. Gascoyne, Brian Skinnider, Kerry J. Savage
Journal: Blood (2012)
Mitochondrial-Mediated Apoptosis by the Sesquiterpene Oil α-Bisabolol and Its Synergism with Imatinib and Nilotinib In BCR-ABL+ Cells
Authors: Massimiliano Bonifacio, Antonella Rigo, Elisabetta Cavalieri, Emanuele Guardalben, Christian Bergamini, Giovanni Pizzolo, Hisanori Suzuki, Fabrizio Vinante
Journal: Blood (2010)
Validation of a Molecular Risk Score for Prognosis of Patients with Acute Promyelocytic Leukemia
Authors: Anna Hecht, Seraphina Doll, Heidi Schaarschmidt, Daniel Nowak, Verena Nowak, Julia Obländer, Christina Xanthopoulos, Eva Lengfelder, Christoph Röllig, Gerhard Ehninger, Wolf-Karsten Hofmann, Uwe Platzbecker
Journal: Blood (2016)
Temsirolimus, An mTOR Inhibitor, In Combination with Low-Dose Clofarabine in Older Patients with Advanced Acute Myeloid Leukemia: Results of a Phase 2 GIMEMA Study (AML-1107)
Authors: Sergio Amadori, Adriano Venditti, Emanuele Ammatuna, Alberto M. Martelli, Giovanna Meloni, Fabrizio Pane, Giovanni Martinelli, Monia Lunghi, Livio Pagano, Daniela Cilloni, Vittorio Rizzoli, Francesco Di Raimondo, Claudio Fozza, Luciana Annino, Alfonso Piciocchi, Edoardo La Sala, Paola Fazi, Marco Vignetti
Journal: Blood (2010)
A Phase I Study of PD 0332991: Complete CDK4/6 Inhibition and Tumor Response In Sequential Combination with Bortezomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Authors: Ruben Niesvizky, Suzanne Lentzsch, Ashraf Z. Badros, Asher A. Chanan-Khan, Seema B. Singhal, Jeffrey A. Zonder, Ravi Vij, Xiangao Huang, Maurizio DiLiberto, Rachel Courtney, M. Naveed Shaik, Sindy T. Kim, Sophia Randolph, Scott A Ely, Selina Chen-Kiang
Journal: Blood (2010)
Identifying the Zika Virus Target Cell in Malignant Glioma
Authors: Gemma Girdler, Tannia Gracia, Daniel Fountain, Ted Fajardo Jr, Jack Finlay, Clément Hallou, Steve Pollard, Trevor Sweeney, Fanni Gergely, David Rowitch, Harry Bulstrode
Journal: Neuro-Oncology (2019)

Abstract The Zika Virus epidemic of 2015–2016 was associated with striking failure of forebrain development in infants born to infected mothers, resulting in microcephaly. Studies from numerous labs subsequently confirmed a selective effect of the virus on neural stem cell survival, self-renewal and differentiation. The glioma stem cells which drive glioblastoma and other malignant gliomas depend on neural stem cell transcription programs, so that understanding Zika infection in these cells promises valuable insights into future therapy. We describe here: 1) Study of low passage patient-derived glioblastoma cell lines and normal neural stem cells (CRUK Glioma Cellular Genetics Resource) in adherent culture to address the influence of glioma subtype on infectability 2) Application of genetically modified mCherry reporter Zika Virus strains to address the Zika target cell in glioblastoma. 3) Development of a cerebral organoid model to interrogate the differential effects of the virus on tumour cells and surrounding normal brain. 4) Demonstration of Zika infection on primary patient derived tissue in slice culture format Using these tools we find that Zika targets a common stem cell population across tumour subtypes and neural stem cell controls, and in embryonic and primary tumour explants, and that infection is influenced by activity of cholesterol biosynthesis pathways.
High Frequency Of BCR-ABL/t(22;9) Translocation As Detected By RT-PCR and Interphase FISH In Pediatric B-Cell ALL Patients Identifies The Need For Immediate Inclusion Of Tyrosine Kinase Inhibitors In Pediatric ALL Treatment Protocols
Authors: Zafar Iqbal, Tashfin Awan, Tanveer Akhtar, Aleem Aamer, Noreen Sabir, Muhammad Absar, Iqbal Mudassar, Ahmad Mukhtar Khalid, Giuseppe Saglio, Mahmood Rasool, Akhtar Hussain
Journal: Blood (2013)
The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): Objectives and Preliminary Results
Authors: Frédéric Millot, Meinolf Suttorp, Joelle Guilhot, Pietr Sedlacek, Evelina S De Bont, Chi Kong Li, Krzysztof Kalwak, Birgitte Lausen, Culic Srdjana, Marie-Françoise Dresse, Andrea Biondi, André Baruchel
Journal: Blood (2012)
Long-Term Outcome of Allogeneic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia
Authors: Sung-Eun Lee, Sung Soo Park, Young-Woo Jeon, Jae-Ho Yoon, Byung Sik Cho, Ki-Sung Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Hee-Je Kim, Seok-Goo Cho, Dong-Wook Kim, Woo-Sung Min, Jong Wook Lee
Journal: Blood (2016)
Expansion and Transformation of Primary Acute Lymphoblastic Leukemia Cells into Antigen-Presenting Cells using a Novel Culturing System Enables the Generation of Leukemia-Reactive T Cell Responses that Are Effective in Vivo.
Authors: Bart A. Nijmeijer, Marianke L.J. Van Schie, Roel Willemze, J.H. Frederik Falkenburg
Journal: Blood (2004)
Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
Authors: Enchen Zhou, Geerte Hoeke, Zhuang Li, Arthur C Eibergen, Amber W Schonk, Martijn Koehorst, Renze Boverhof, Rick Havinga, Folkert Kuipers, Tamer Coskun, Mariëtte R Boon, Albert K Groen, Patrick C N Rensen, Jimmy F P Berbée, Yanan Wang
Journal: Cardiovascular Research (2019)

Brown fat activation accelerates the uptake of cholesterol-enriched remnants by the liver and thereby lowers plasma cholesterol, consequently protecting against atherosclerosis development. Hepatic cholesterol is then converted into bile acids (BAs) that are secreted into the intestine and largely maintained within the enterohepatic circulation. We now aimed to evaluate the effects of prolonged brown fat activation combined with inhibition of intestinal BA reabsorption on plasma cholesterol metabolism and atherosclerosis development.APOE*3-Leiden.CETP mice with humanized lipoprotein metabolism were treated for 9 weeks with the selective β3-adrenergic receptor (AR) agonist CL316,243 to substantially activate brown fat. Prolonged β3-AR agonism reduced faecal BA excretion (-31%), while markedly increasing plasma levels of total BAs (+258%), cholic acid-derived BAs (+295%), and chenodeoxycholic acid-derived BAs (+217%), and decreasing the expression of hepatic genes involved in BA production. In subsequent experiments, mice were additionally treated with the BA sequestrant Colesevelam to inhibit BA reabsorption. Concomitant intestinal BA sequestration increased faecal BA excretion, normalized plasma BA levels, and reduced hepatic cholesterol. Moreover, concomitant BA sequestration further reduced plasma total cholesterol (-49%) and non-high-density lipoprotein cholesterol (-56%), tended to further attenuate atherosclerotic lesion area (-54%). Concomitant BA sequestration further increased the proportion of lesion-free valves (+34%) and decreased the relative macrophage area within the lesion (-26%), thereby further increasing the plaque stability index (+44%).BA sequestration prevents the marked accumulation of plasma BAs as induced by prolonged brown fat activation, thereby further improving cholesterol metabolism and reducing atherosclerosis development. These data suggest that combining brown fat activation with BA sequestration is a promising new therapeutic strategy to reduce hyperlipidaemia and cardiovascular diseases.
ITIM-Containing Inhibitory Receptors Are Required to Balance Oncogenic Signaling Strength in Ph+ ALL
Authors: Zhengshan Chen, Huimin Geng, Maike Buchner, Lars Klemm, Kaveh Hemati, Seyedmehdi Shojaee, Mak W Tak, John E Coligan, William L. Carroll, Cheryl L Willman, Markus Muschen
Journal: Blood (2012)
A 3-Bp Deletion Between Transcription Factor Binding Motifs In the HBS1L-MYB Intergenic Region on Chromosome 6q23 Is Associated with HbF Expression
Authors: John J. Farrell, Richard M. Sherva, Zhi-yi Chen, Luo Hong-yuan, Banjamin F. Chu, Shau Yin Ha, Chi Kong Li, Anselm C.W. Lee, Chi Keung Li, Hui Leung Yuen, Jason C.C. So, Edmond ShiuKwan Ma, Li Chong Chan, Vivian Chan, Paola Sebastiani, Lindsay A. Farrer, Clinton T. Baldwin, Martin H. Steinberg, David H.K. Chui
Journal: Blood (2010)
Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics
Authors: Deborah Dowell, Wilson M. Compton, Brett P. Giroir
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Differences in Genomic Patterns and Clinical Outcomes Between African-American and White Patients with Myelodysplastic Syndromes (MDS)
Authors: Aziz Nazha, Tomas Radivoyevitch, David J. Seastone, Brittney Dienes, Bartlomiej P Przychodzen, Jennifer S. Carew, Sudipto Mukherjee, Hetty E. Carraway, Anjali S. Advani, Matt E. Kalaycio, Sean Hobson, Gina Rupp, Kristin Colaluca, Aaron T. Gerds, Jaroslaw P. Maciejewski, Mikkael A. Sekeres
Journal: Blood (2014)
Haploidentical Stem Cell Transplantation without T Cell Depletion: A Brazilian Protocol.
Authors: Belinda P. Simoes, George Navarro, Maria C. Favarin, Leonardo C. Palma, Maria I. Ayrosa, Carlos E. Velano, Fabiano Pieroni, Ana Beatriz P.L. Stracieri, Daniela Moraes, Maria C. Oliveira, Julio C. Voltarelli
Journal: Blood (2006)
Platelet Antiaggregant Therapy Prevents Venous Thrombosis in Patients with JAK2 V617F Positive Essential Thrombocythemia without Indication of Cytoreductive Treatment.
Authors: Alberto Alvarez-Larrán, Francisco Cervantes, Eduardo Arellano-Rodrigo, Virginia Pérez-Andreu, Juan-Carlos Hernández-Boluda, Carlos Salvador, Ramón Ayats, Anna Muntañola, Beatriz Bellosillo, Vicente Vicente, Carmen Burgaleta, Anna Gaya, Luis Hernández-Nieto, Blanca Xicoy, Carlos Besses
Journal: Blood (2009)